Sensorimotor Control During Postural Transitions in CP

Last updated: May 1, 2024
Sponsor: University of Delaware
Overall Status: Active - Recruiting

Phase

N/A

Condition

Cerebral Palsy

Treatment

Stochastic Resonance Electric Stimulation

Clinical Study ID

NCT05384990
1759703
  • Ages 10-21
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to investigate whether a light electrical stimulation to leg muscles and joints can help people with Cerebral Palsy (CP) maintain balance during everyday tasks such as getting up from a chair and walking. Children and young adults with CP can have trouble with daily tasks such as standing up, sitting down on the chair and turning. The difficulty in maintaining balance sometimes lead to falls. This raises risk of disability in CP as children age into teens and adults. Current treatments are not very effective. In this study, children and young adults will be asked to stand up from a stool, walk in a straight line, turn, walk back and sit down on the stool. Participants will receive electrical stimulation at a very low intensity that cannot be felt to help increase their sensory perception. The investigators will evaluate treatment by testing balance, and other functional measures.

Eligibility Criteria

Inclusion

Inclusion Criteria for individuals with CP:

  1. Age 10-21

  2. Diagnosis of CP

  3. GMFCS level I-II

  4. Ability to stand up from a chair and start walking.

  5. Migration index of proximal hip (MIGR) < 40% femoral head covering in acetabulum

  6. At least 0° passive dorsiflexion range of motion (ROM)

  7. Sufficient visuoperceptual, cognitive and communication skills

  8. Seizure-free or well-controlled seizures

  9. No other neurological or musculoskeletal disorders (e.g. dystonia, severe scoliosis, hip instability

  10. Ability to communicate pain or discomfort

  11. Ability to assent/consent or obtain parent/guardian consent

Exclusion Criteria for individuals with CP:

  1. Scoliosis with primary curve > 40%

  2. Spinal fusions extending into pelvis

  3. Lower Extremity joint instability or dislocation

  4. Severe tactile hypersensitivity

  5. Lower extremity botulinum injections in the past 6 months

  6. Implanted medical device or metal contraindicative of the application of SR

  7. Pregnancy (self-reported)

  8. Severe lower extremity spasticity (Modified Ashworth Scale score of 4 or greater)

  9. History of pulmonary disease limiting exercise tolerance (Asthma Control Test screen)

  10. History of cardiac disease (American Heart Association screen)

  11. Severely limited range of joint motion/ irreversible muscle contractures

  12. Lower extremity surgery or significant injury within last 1 yr.

Inclusionary criteria for typically developing volunteers:

  1. Aged 10-21 years old

  2. Ability to stand up from a chair and start walking without an assistive device or orthoses

  3. Able to communicate discomfort during testing and can follow multi-step directions

  4. Has not been diagnosed with any neurological or balance disorders

  5. Seizure-free

Exclusionary criteria for typically developing volunteers:

  1. Diagnosis of CP

  2. Significant scoliosis with primary curve > 40°

  3. Lower extremity surgery or fractures in the year prior testing

  4. Joint instability or dislocation in the lower extremities

  5. Severe tactile hypersensitivity

  6. A history of selective dorsal root rhizotomy

  7. Botulinum toxin injections in the lower extremities within the past 6 months

  8. Marked visual or hearing deficits

  9. Any embedded metal that may be contraindicated with application of SR

  10. Severe spasticity of the lower extremity muscles (eg. a score of 4 on the Modified Ashworth)

  11. Pregnancy (self-reported)

  12. Severely limited joint range of motion/ irreversible muscle contractures that would not be candidates for soft-tissue surgery

  13. Learning disabilities

  14. History of neurological disorders

  15. Balance and/or postural impairment

Study Design

Total Participants: 36
Treatment Group(s): 1
Primary Treatment: Stochastic Resonance Electric Stimulation
Phase:
Study Start date:
April 01, 2024
Estimated Completion Date:
May 31, 2025

Connect with a study center

  • University of Delaware

    Newark, Delaware 19713
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.